Notable Publications - May Update
A small selection of recent notable publications from around the world
What matters to Proteintech is the success of its antibodies in the hands of scientists.
Here’s just a small selection of publications featuring Proteintech products from March - May 2017.
|
1. Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice. 3. Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis. |
Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice.
L Becker and B Huang et al
Nature 544, 367–371 (20 April 2017)
Country: US
Institution: Department of Genetics, Stanford University School of Medicine
Cited products: TDP-43 (12892-1-AP)
| TDP-43 (C-Terminal) Antibody | |
| KD/KO Validated | Catalog number: 12892-1-AP |
| 59 Publications | Applications: ELISA, chip, IF, IHC, IP, WB |
5-methylcytosine promotes mRNA export - NSUN2 as the methyltransferase and ALYREF as an m(5)C reader.
X Yang and Y Yang et al
Cell Research (2017) 27:606–625
Country: China
Institution: Center for Reproductive Medicine, The First Affiliated Hospital of Zhengzhou University
Cited Products: NSUN2 (20854-1-AP)
| NSUN2 Antibody | |
| KD/KO Validated | Catalog number: 20854-1-AP |
| 7 Publications | Applications: ELISA, IF, IHC, IP, WB |
Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis.
L Romani and V Oikonomou et al
Nature Medicine (2017)
Country: Italy
Institution: Department of Experimental Medicine, University of Perugia
Cited Products: USP36 (14783-1-AP)
Transcription Impacts the Efficiency of mRNA Translation via Co-transcriptional N6-adenosine Methylation.
| METTL3 Antibody | |
| KD/KO Validated | Catalog number: 15073-1-AP |
| 12 Publications | Applications: ELISA, IF, IHC, IP, WB |
Inherited GINS1 deficiency underlies growth retardation along with neutropenia and NK cell deficiency.
